Oncothyreon Inc . Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (21)

View All

Latest Posts

About This Stock More About This Stock
Thursday Morning Pre-Market Insights: EXAS, AVEO, ONTY, DBVT
Article By: TipRanks
Thursday, June 4, 2015 8:33 AM EDT
Thursday morning pre-market insights: EXAS, AVEO, ONTY, DBVT.
In this article: ONTY, AVEO, EXAS, DBVT
Read
H.C. Wainwright Offers Updates On: ONTY, ARIA, AGEN
Article By: TipRanks
Tuesday, June 2, 2015 10:34 AM EDT
H.C. Wainright analyst Reni Benjamin attended several presentations and offered highlights on Oncothyreon Inc.(U.S.A), Ariad Pharmaceuticals, Inc. and Agenus Inc.
In this article: ARIA, ONTY, AGEN
Read
ONTY And CLDX Announce Initiation Of Immunotherapy Clinical Trials; NPSP Initiates Study Of Teduglutide
Article By: BioMedReports
Tuesday, November 11, 2014 3:05 AM EDT
ONTY and CLDX announced they have initiated a combined clinical trial of ONT-10 and varlilumab. NPSP announced the company has initiated a global registration study of teduglutide in pediatric patients.
In this article: CLDX, NPSP, ONTY
Read
EC Bioniche: A Home Run Buying Opportunity In Biotech
Article By: SecretCaps
Thursday, September 18, 2014 9:38 AM EDT
There is a critical medical need for Bioniche's technology in a $1 billion market virtually free of real competition, which opens the door for massive revenue growth, while the sound financials limits downside risk. Overall, today's $0.20 share price appears to me as an excellent entry point...
In this article: BNHLF, ECYT, ONTY, GALE
Read
All Posts

PARTNER HEADLINES

Latest Tweets for $ONTY

No tweets yet!